Free Trial
NASDAQ:LFST

LifeStance Health Group (LFST) Stock Price, News & Analysis

LifeStance Health Group logo
$12.22 +0.39 (+3.30%)
Closing price 04:00 PM Eastern
Extended Trading
$11.99 -0.23 (-1.90%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About LifeStance Health Group Stock (NASDAQ:LFST)

Advanced

Key Stats

Today's Range
$11.83
▼
$12.24
50-Day Range
$10.26
▼
$13.38
52-Week Range
$4.77
▼
$13.56
Volume
3.23 million shs
Average Volume
5.75 million shs
Market Capitalization
$4.67 billion
P/E Ratio
94.01
Dividend Yield
N/A
Price Target
$13.13
Consensus Rating
Moderate Buy

Company Overview

LifeStance Health Group, Inc. is a U.S.-based healthcare company that provides outpatient mental health services through a network of clinicians. Its services are delivered through both in-person appointments and a virtual care platform, allowing patients to access care in a range of settings.

The company offers psychiatric evaluation and treatment, psychotherapy, medication management, psychological and neuropsychological testing, and related behavioral health services. LifeStance serves children, adolescents, and adults, addressing conditions such as anxiety, depression, attention-deficit/hyperactivity disorder, and other mental health and behavioral concerns.

LifeStance operates across multiple states in the United States and combines company-operated clinics with telehealth services. The company was founded in 2017 and became a publicly traded company on the Nasdaq in 2021. Its leadership includes Chief Executive Officer Danish Qureshi, who has overseen the company’s efforts to expand access to coordinated mental healthcare.

AI Generated. May Contain Errors.

LifeStance Health Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
74th Percentile Overall Score

LFST MarketRank™: 

LifeStance Health Group scored higher than 74% of companies evaluated by MarketBeat, and ranked 275th out of 888 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    LifeStance Health Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on 1 strong buy rating, 6 buy ratings, 4 hold ratings, and no sell ratings.

  • Upside/Downside

    The consensus price target for LifeStance Health Group is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    LifeStance Health Group has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about LifeStance Health Group's stock forecast and price target.
  • Earnings Growth

    Earnings for LifeStance Health Group are expected to grow by 43.75% in the coming year, from $0.16 to $0.23 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of LifeStance Health Group is 91.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.95.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of LifeStance Health Group is 91.00, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.64.

  • Price to Book Value per Share Ratio

    LifeStance Health Group has a P/B Ratio of 3.13. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about LifeStance Health Group's valuation and earnings.
  • Percentage of Shares Shorted

    4.41% of the float of LifeStance Health Group has been sold short.
  • Short Interest Ratio / Days to Cover

    LifeStance Health Group has a short interest ratio ("days to cover") of 3.07, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in LifeStance Health Group has recently increased by 19.38%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    LifeStance Health Group does not currently pay a dividend.

  • Dividend Growth

    LifeStance Health Group does not have a long track record of dividend growth.

  • News Sentiment

    LifeStance Health Group has a news sentiment score of 0.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for LifeStance Health Group this week, compared to 4 articles on an average week.
  • Search Interest

    5 people have searched for LFST on MarketBeat in the last 30 days. This is an increase of 400% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added LifeStance Health Group to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, LifeStance Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $146,433,781.00 in company stock.

  • Percentage Held by Insiders

    3.50% of the stock of LifeStance Health Group is held by insiders.

  • Percentage Held by Institutions

    85.50% of the stock of LifeStance Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about LifeStance Health Group's insider trading history.
Receive LFST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeStance Health Group and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LFST Stock News Headlines

Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.tc pixel
What’s Going On With LifeStance Health Group (LFST)?
LifeStance Health CTO Sells 42,067 Shares for $541,402
See More Headlines

LFST Stock Analysis - Frequently Asked Questions

LifeStance Health Group's stock was trading at $7.04 at the start of the year. Since then, LFST stock has increased by 73.6% and is now trading at $12.22.

LifeStance Health Group, Inc. (NASDAQ:LFST) issued its quarterly earnings results on Thursday, August, 6th. The company reported $0.06 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.03 by $0.03. The firm's quarterly revenue was up 26.1% on a year-over-year basis.
Read the conference call transcript
.

LifeStance Health Group's Board of Directors initiated a stock buyback program on Wednesday, February 25th 2026, which permits the company to buy back $100,000,000 in shares, according to EventVestor. This means that the company could buy up to 3.6% of its shares through open market purchases. Shares buyback programs are typically a sign that the company's management believes its shares are undervalued.

LifeStance Health Group (LFST) raised $640 million in an initial public offering (IPO) on Wednesday, June 9th 2021. The company issued 40,000,000 shares at a price of $15.00-$17.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan, Jefferies, TPG Capital BD LLC, UBS Investment Bank and William Blair served as the underwriters for the IPO and Capital One Securities, AmeriVet, Drexel Hamilton, R. Seelaus & Co. and Siebert Williams Shank were co-managers.

Shares of LFST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that LifeStance Health Group investors own include Waste Connections (WCN), American Water Works (AWK), The RMR Group (RMR), AUO (AUOTY), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
8/06/2026
Today
10/05/2026
Next Earnings (Estimated)
11/05/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NASDAQ:LFST
CIK
1845257
Fax
N/A
Employees
10,961
Year Founded
2017

Price Target and Rating

High Price Target
$18.00
Low Price Target
$8.00
Potential Upside/Downside
+7.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.73
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.13
Trailing P/E Ratio
91.00
Forward P/E Ratio
76.38
P/E Growth
N/A
Net Income
$9.66 million
Net Margins
3.19%
Pretax Margin
4.23%
Return on Equity
3.39%
Return on Assets
2.33%

Debt

Debt-to-Equity Ratio
0.18
Current Ratio
1.38
Quick Ratio
1.38

Sales & Book Value

Annual Sales
$1.42 billion
Price / Sales
3.28
Cash Flow
$0.17 per share
Price / Cash Flow
70.33
Book Value
$3.91 per share
Price / Book
3.13

Miscellaneous

Outstanding Shares
382,150,000
Free Float
368,779,000
Market Cap
$4.67 billion
Optionable
Optionable
Beta
1.24

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:LFST) was last updated on 10/5/2026 by MarketBeat.com Staff.
From Our Partners